Sanara MedTech
SMTI
21 hedge funds and large institutions have $5.45M invested in Sanara MedTech in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 21 → 21 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.34% less ownership
Funds ownership: 3.61% → 3.27% (-0.34%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
30% less capital invested
Capital invested by funds: $7.79M → $5.45M (-$2.34M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$256K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$19.7K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.1K |
| 4 |
Lazard Asset Management
New York
|
+$14.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$416K |
| 2 |
State Street
Boston,
Massachusetts
|
-$222K |
| 3 |
LCM
Laurion Capital Management
New York
|
-$65K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$21.2K |
| 5 |
Morgan Stanley
New York
|
-$18.8K |
SMTI Hedge Fund Activity: Q2 2022 in Review
21 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q2 2022, worth a combined $5.45M — down 30% from $7.79M a quarter earlier.
Fund positioning in SMTI was balanced in Q2 2022: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 5 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $256K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $416K sold.
- 21 institutional investors held Sanara MedTech (SMTI) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $5.45M of Sanara MedTech stock for Q2 2022, down 30% quarter-over-quarter.
- 2 funds opened new Sanara MedTech positions in Q2 2022 and 2 closed out, a net change of 0 holders.
- The largest Sanara MedTech buyer in Q2 2022 was Citadel Advisors, an estimated $256K added.
- The largest Sanara MedTech seller in Q2 2022 was Susquehanna International Group, an estimated $416K sold.
Based on aggregated 13F filings for Q2 2022.